Healthcare & Life Sciences
Bluebird Bio
United Statesbluebirdbio.com
Bluebird Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
1992
Founded
2
Investors
About Bluebird Bio
Bluebird Bio is a company founded in 1992 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Bluebird Bio, now rebranded as Genetix Biotherapeutics, develops and commercializes genetic therapies based on gene-modified autologous blood stem cells to treat rare genetic diseases such as sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
Explore Bluebird Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.